{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:59:59Z","timestamp":1792184399128,"version":"4.4.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.pupt.2026.102410","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T07:16:07Z","timestamp":1770016567000},"page":"102410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The importance of biomarkers in the treatable-trait approach to chronic airway diseases"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4895-9707","authenticated-orcid":false,"given":"Mario","family":"Cazzola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Maniscalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriella","family":"Matera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rogliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2026.102410_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.108421","article-title":"Treatable traits. Why, what, how?","volume":"249","author":"Agusti","year":"2025","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.pupt.2026.102410_bib2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaip.2023.01.011","article-title":"Treatable traits in airway disease: from theory to practice","volume":"11","author":"Agusti","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"5","key":"10.1016\/j.pupt.2026.102410_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02058-2018","article-title":"Treatable traits: a new paradigm for 21st century management of chronic airway diseases: treatable traits Down under international workshop report","volume":"53","author":"McDonald","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2026.102410_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.108333","article-title":"Comorbidities as treatable traits of chronic airway diseases","volume":"248","author":"Cazzola","year":"2025","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.pupt.2026.102410_bib5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12931-025-03356-w","article-title":"Toward precision medicine in COPD: phenotypes, endotypes, biomarkers, and treatable traits","volume":"26","author":"Xie","year":"2025","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.pupt.2026.102410_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41533-024-00381-y","article-title":"Change is in the air: key questions on the 'Treatable Traits' model for chronic airway diseases in primary care","volume":"34","author":"Agusti","year":"2024","journal-title":"NPJ Prim. Care Respir. Med."},{"issue":"10","key":"10.1016\/j.pupt.2026.102410_bib9","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3390\/diagnostics15101245","article-title":"The emerging biomarkers in chronic obstructive pulmonary disease: a narrative review","volume":"15","author":"Phillips","year":"2025","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"10.1016\/j.pupt.2026.102410_bib10","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jaci.2021.11.021","article-title":"Considering biomarkers in asthma disease severity","volume":"149","author":"Custovic","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.pupt.2026.102410_bib11","doi-asserted-by":"crossref","unstructured":"Cant E, Bottier M, Shuttleworth M, et al. Inflammatory and mucociliary dysfunction-based endotypes across the spectrum of chronic airway diseases. Chest. Published online August 26, 2025. doi:10.1016\/j.chest.2025.07.4087.","DOI":"10.1016\/j.chest.2025.07.4087"},{"issue":"10","key":"10.1016\/j.pupt.2026.102410_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302318","article-title":"High blood eosinophils predict the risk of COPD exacerbation: a systematic review and meta-analysis","volume":"19","author":"Chen","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pupt.2026.102410_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1164\/rccm.202201-0209PP","article-title":"Blood eosinophils and chronic obstructive pulmonary disease: a global initiative for chronic obstructive lung disease science committee 2022 review","volume":"206","author":"Singh","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.pupt.2026.102410_bib14","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1164\/rccm.202109-2093ST","article-title":"Use of fractional exhaled nitric oxide to guide the treatment of asthma: an official American thoracic society clinical practice guideline","volume":"204","author":"Khatri","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10379","key":"10.1016\/j.pupt.2026.102410_bib15","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(22)02125-0","article-title":"Asthma","volume":"401","author":"Porsbjerg","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.pupt.2026.102410_bib16","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/1744666X.2025.2525443","article-title":"Biologics for severe asthma: deciphering what is best for the patient","volume":"21","author":"Cazzola","year":"2025","journal-title":"Expet Rev. Clin. Immunol."},{"issue":"22","key":"10.1016\/j.pupt.2026.102410_bib17","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1001\/jama.2020.21974","article-title":"Managing asthma in adolescents and adults: 2020 asthma guideline update from the national asthma education and prevention program","volume":"324","author":"Cloutier","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.pupt.2026.102410_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/thoraxjnl-2020-214644","article-title":"Eosinophilia and fractional exhaled nitric oxide levels in chronic obstructive lung disease","volume":"77","author":"Annangi","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2026.102410_bib19","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.2147\/COPD.S167600","article-title":"Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap","volume":"13","author":"Takayama","year":"2018","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"37","key":"10.1016\/j.pupt.2026.102410_bib20","article-title":"Predictors of fractional exhaled nitric oxide response to inhaled corticosteroid therapy in chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"104","author":"Lee","year":"2025","journal-title":"Medicine (Baltim.)"},{"issue":"3","key":"10.1016\/j.pupt.2026.102410_bib21","first-page":"387","article-title":"Asthma biomarkers in sputum","volume":"32","author":"Spahn","year":"2012","journal-title":"Immunol. Allergy Clin."},{"issue":"9979","key":"10.1016\/j.pupt.2026.102410_bib22","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(15)60693-6","article-title":"Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management","volume":"385","author":"Woodruff","year":"2015","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.pupt.2026.102410_bib23","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJMra1608969","article-title":"Severe and difficult-to-treat asthma in adults","volume":"377","author":"Israel","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.pupt.2026.102410_bib24","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1164\/rccm.202303-0499OC","article-title":"Inflammatory molecular endotypes in bronchiectasis: a European multicenter cohort study","volume":"208","author":"Choi","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.pupt.2026.102410_bib25","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jaci.2016.02.001","article-title":"Relationship between lung function and quantitative computed tomographic parameters of airway remodeling, air trapping, and emphysema in patients with asthma and chronic obstructive pulmonary disease: a single-center study","volume":"137","author":"Hartley","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.pupt.2026.102410_bib26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1148\/radiol.12111270","article-title":"Chronic obstructive pulmonary disease: CT quantification of airways disease","volume":"265","author":"Hackx","year":"2012","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.pupt.2026.102410_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1148\/rg.2020190099","article-title":"Quantitative CT analysis of diffuse lung disease","volume":"40","author":"Chen","year":"2020","journal-title":"Radiographics"},{"issue":"11","key":"10.1016\/j.pupt.2026.102410_bib28","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.ejrad.2016.09.010","article-title":"Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: relationship to physiological measurements, clinical index and visual assessment of airway disease","volume":"85","author":"Nambu","year":"2016","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.pupt.2026.102410_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105954","article-title":"Diagnosis and quantification of bronchiectasis using computed tomography or magnetic resonance imaging: a systematic review","volume":"170","author":"Meerburg","year":"2020","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.pupt.2026.102410_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1001\/jama.2025.2680","article-title":"Non-cystic fibrosis bronchiectasis in adults: a review","volume":"334","author":"Barker","year":"2025","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.pupt.2026.102410_bib31","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00330-024-11019-5","article-title":"Artificial intelligence-driven volumetric CT outcome score in cystic fibrosis: longitudinal and multicenter validation with\/without modulators treatment","volume":"35","author":"Hadj Bouzid","year":"2025","journal-title":"Eur. Radiol."},{"issue":"12","key":"10.1016\/j.pupt.2026.102410_bib32","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1164\/rccm.202009-3448OC","article-title":"Inflammatory endotype-associated airway microbiome in chronic obstructive pulmonary disease clinical stability and exacerbations: a multicohort longitudinal analysis","volume":"203","author":"Wang","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"10.1016\/j.pupt.2026.102410_bib33","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1164\/rccm.201203-0507OC","article-title":"Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis","volume":"186","author":"Sagel","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"10.1016\/j.pupt.2026.102410_bib34","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/s41564-022-01196-8","article-title":"Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions","volume":"7","author":"Yan","year":"2022","journal-title":"Nat. Microbiol."},{"issue":"1","key":"10.1016\/j.pupt.2026.102410_bib35","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1038\/s41598-023-32901-0","article-title":"Lung microbiome and cytokine profiles in different disease states of COPD: a cohort study","volume":"13","author":"Xue","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.pupt.2026.102410_bib36","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00588-2019","article-title":"Management of severe asthma: a European respiratory society\/American thoracic society guideline","volume":"55","author":"Holguin","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.pupt.2026.102410_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2213-2600(24)00299-6","article-title":"Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial","volume":"13","author":"Ramakrishnan","year":"2025","journal-title":"Lancet Respir. Med."},{"issue":"17","key":"10.1016\/j.pupt.2026.102410_bib38","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1056\/NEJMoa2413181","article-title":"Mepolizumab to prevent exacerbations of COPD with an eosinophilic phenotype","volume":"392","author":"Sciurba","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.pupt.2026.102410_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S2213-2600(23)00298-9","article-title":"Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial","volume":"12","author":"Ramakrishnan","year":"2024","journal-title":"Lancet Respir. Med."},{"issue":"10","key":"10.1016\/j.pupt.2026.102410_bib40","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s00134-025-08089-4","article-title":"Temporal stability of phenotypes of acute respiratory distress syndrome: clinical implications for early corticosteroid therapy and mortality","volume":"51","author":"Pensier","year":"2025","journal-title":"Intensive Care Med."},{"issue":"11","key":"10.1016\/j.pupt.2026.102410_bib42","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1164\/rccm.202303-0499OC","article-title":"Inflammatory molecular endotypes in bronchiectasis: a European multicenter cohort study","volume":"208","author":"Choi","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.pupt.2026.102410_bib43","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00408-024-00707-0","article-title":"Type 2 biomarkers and their clinical implications in bronchiectasis: a prospective cohort study","volume":"202","author":"Chen","year":"2024","journal-title":"Lung"},{"issue":"11","key":"10.1016\/j.pupt.2026.102410_bib44","first-page":"1532","article-title":"Biomarkers of progression of chronic obstructive pulmonary disease (COPD)","volume":"6","author":"Shaw","year":"2014","journal-title":"J. Thorac. Dis."},{"issue":"Suppl 4","key":"10.1016\/j.pupt.2026.102410_bib45","doi-asserted-by":"crossref","first-page":"S234","DOI":"10.1513\/AnnalsATS.201808-533MG","article-title":"Targeting chronic obstructive pulmonary disease phenotypes, endotypes, and biomarkers","volume":"15","author":"Garudadri","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"3","key":"10.1016\/j.pupt.2026.102410_bib41","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00081-2025","article-title":"Neutrophil-derived biomarkers in bronchiectasis: identifying a common therapeutic target","volume":"66","author":"Chalmers","year":"2025","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.pupt.2026.102410_bib46","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01509-2019","article-title":"Targeting treatable traits in severe asthma: a randomised controlled trial","volume":"55","author":"McDonald","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.pupt.2026.102410_bib47","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00861-2024","article-title":"Integrating hot topics and implementation of treatable traits in asthma","volume":"64","author":"Gibson","year":"2024","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.pupt.2026.102410_bib48","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.3390\/cells10113263","article-title":"Treatable traits in chronic respiratory disease: a comprehensive review","volume":"10","author":"Lee","year":"2021","journal-title":"Cells"},{"issue":"171","key":"10.1016\/j.pupt.2026.102410_bib49","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0143-2023","article-title":"From treatable traits to GETomics in airway disease: moving towards clinical practice","volume":"33","author":"Papi","year":"2024","journal-title":"Eur. Respir. Rev."},{"issue":"5","key":"10.1016\/j.pupt.2026.102410_bib50","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.chest.2020.11.011","article-title":"A cluster analysis of bronchiectasis patients based on the airway immune profile","volume":"159","author":"Perea","year":"2021","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.pupt.2026.102410_bib51","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jcf.2021.10.009","article-title":"Inflammation biomarkers in sputum for clinical trials in cystic fibrosis: current understanding and gaps in knowledge","volume":"21","author":"Lepissier","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.pupt.2026.102410_bib52","article-title":"Critical evaluation of asthma biomarkers in clinical practice","volume":"9","author":"Guida","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"10277","key":"10.1016\/j.pupt.2026.102410_bib53","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(21)00458-X","article-title":"Improving lung health in low-income and middle-income countries: from challenges to solutions","volume":"397","author":"Meghji","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.pupt.2026.102410_bib54","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S2213-2600(25)00037-2","article-title":"Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials","volume":"13","author":"Meulmeester","year":"2025","journal-title":"Lancet Respir. Med."},{"issue":"9","key":"10.1016\/j.pupt.2026.102410_bib55","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(17)30217-5","article-title":"Eosinophils in COPD: just another biomarker?","volume":"5","author":"Bafadhel","year":"2017","journal-title":"Lancet Respir. Med."},{"issue":"7","key":"10.1016\/j.pupt.2026.102410_bib56","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/biom13071118","article-title":"Type 2 low biomarker stability and exacerbations in severe uncontrolled asthma","volume":"13","author":"Viinanen","year":"2023","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.pupt.2026.102410_bib57","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.jaip.2023.02.020","article-title":"Clinical implications of longitudinal blood eosinophil counts in patients with severe asthma","volume":"11","author":"Bleecker","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"5","key":"10.1016\/j.pupt.2026.102410_bib58","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2967\/jnumed.120.251520","article-title":"Statistical considerations in the evaluation of continuous biomarkers","volume":"62","author":"Polley","year":"2021","journal-title":"J. Nucl. Med."},{"issue":"7","key":"10.1016\/j.pupt.2026.102410_bib59","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/aps.2018.29","article-title":"Multiplex biomarker approach to cardiovascular diseases","volume":"39","author":"Adamcova","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.pupt.2026.102410_bib60","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbi.2022.09.011","article-title":"A systematic review and meta-analysis of the stability of peripheral immune markers in healthy adults","volume":"107","author":"Walsh","year":"2023","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.pupt.2026.102410_bib61","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cmi.2022.08.026","article-title":"Use of biomarkers to individualize antimicrobial therapy duration: a narrative review","volume":"29","author":"Scott","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"issue":"5","key":"10.1016\/j.pupt.2026.102410_bib62","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ajhg.2024.03.016","article-title":"Genomic answers for kids: toward more equitable access to genomic testing for rare diseases in rural populations","volume":"111","author":"Cohen","year":"2024","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.pupt.2026.102410_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.63990","article-title":"Genetic services in appalachia conference series","volume":"197","author":"Kelly","year":"2025","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.pupt.2026.102410_bib64","article-title":"\"Equity\" in genomic health policies: a review of policies in the international arena","volume":"12","author":"Basnayake","year":"2024","journal-title":"Front. Public Health"},{"issue":"3","key":"10.1016\/j.pupt.2026.102410_bib65","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/cpt.2818","article-title":"Multi-omics studies in historically excluded populations: the road to equity","volume":"113","author":"Yang","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.pupt.2026.102410_bib66","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10142-023-00979-4","article-title":"Health inequity in genomic personalized medicine in underrepresented populations: a look at the current evidence","volume":"23","author":"Tawfik","year":"2023","journal-title":"Funct. Integr. Genomics"},{"issue":"12","key":"10.1016\/j.pupt.2026.102410_bib67","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/resp.14610","article-title":"The treatable traits approach to adults with obstructive airways disease in primary and secondary care","volume":"28","author":"Thomas","year":"2023","journal-title":"Respirology"},{"issue":"10","key":"10.1016\/j.pupt.2026.102410_bib68","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/all.13806","article-title":"Toward clinically applicable biomarkers for asthma: an EAACI position paper","volume":"74","author":"Diamant","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.pupt.2026.102410_bib69","doi-asserted-by":"crossref","unstructured":"Su L, Chen L, Betigeri S, et al. Clinical trials with pragmatic elements: a review of use cases and real-world data utilization. Clin. Pharmacol. Ther. Published online August 19, 2025. doi:10.1002\/cpt.70033.","DOI":"10.1002\/cpt.70033"},{"issue":"7955","key":"10.1016\/j.pupt.2026.102410_bib70","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41586-023-05844-9","article-title":"An atlas of genetic scores to predict multi-omic traits","volume":"616","author":"Xu","year":"2023","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pupt.2026.102410_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100561","article-title":"Multi-omics profiling for health","volume":"22","author":"Babu","year":"2023","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.pupt.2026.102410_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2023.115387","article-title":"The convergence of traditional and digital biomarkers through AI-assisted biosensing: a new era in translational diagnostics?","volume":"235","author":"Arya","year":"2023","journal-title":"Biosens. Bioelectron."},{"issue":"Suppl 1","key":"10.1016\/j.pupt.2026.102410_bib74","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11121-023-01589-z","article-title":"Enhancing impact: a call to action for equitable implementation science","volume":"25","author":"Shelton","year":"2024","journal-title":"Prev. Sci."},{"issue":"19","key":"10.1016\/j.pupt.2026.102410_bib73","doi-asserted-by":"crossref","first-page":"e1143","DOI":"10.1161\/CIR.0000000000001231","article-title":"Implementation science to achieve equity in heart failure care: a scientific statement from the American heart association","volume":"149","author":"Breathett","year":"2024","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.pupt.2026.102410_bib75","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1080\/02770903.2024.2361783","article-title":"Biomarkers in asthma, potential for therapeutic intervention","volume":"61","author":"Pasha","year":"2024","journal-title":"J. Asthma"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553926000039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553926000039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:34:35Z","timestamp":1774654475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553926000039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":73,"alternative-id":["S1094553926000039"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2026.102410","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The importance of biomarkers in the treatable-trait approach to chronic airway diseases","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2026.102410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102410"}}